Page 366 - fbkCardioDiabetes_2017
P. 366
Evaluvation of Cardiac Syncope And ECG Markers of
342
Sudden Cardiac Arrest.
saddle shaped ST elevation in V1-2 also may be seen 2. Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD,
on the ECG. et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management
of Patients with Syncope: A Report of the American College of Cardiology/
American Heart Association Task Force on Clinical Practice Guidelines, and
the Heart Rhythm Society. Heart Rhythm. 2017.
3. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine
(Baltimore). 1990;69(3):160-75.
4. Brignole M, Disertori M, Menozzi C, Raviele A, Alboni P, Pitzalis MV, et
al. Management of syncope referred urgently to general hospitals with and
without syncope units. Europace. 2003;5(3):293-8.
5. Blanc JJ. [The best of 2001. Heart stimulation]. Arch Mal Coeur Vaiss.
2002;95 Spec No 1(5 Spec 1):29-32.
6. Linzer M, Prystowsky EN, Divine GW, Matchar DB, Samsa G, Harrell F,
Fig 9: Type A WPW syndrome with positive R in V1 Jr., et al. Predicting the outcomes of electrophysiologic studies of patients
with right precordial T wave inversions. with unexplained syncope: preliminary validation of a derived model. J Gen
Intern Med. 1991;6(2):113-20.
7. Jha S, Nag D. Sympathetic skin response and autonomic dysfunction in
diabetes. Indian J Physiol Pharmacol. 1995;39(2):149-53.
8. Dandona P, James IM, Woollard ML, Newbury P, Beckett AG. Insta-
bility of cerebral blood-flow in insulin-dependent diabetics. Lancet.
1979;2(8154):1203-5.
9. Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, et
al. Mortality in patients after a recent myocardial infarction: a randomized,
placebo-controlled trial of azimilide using heart rate variability for risk
stratification. Circulation. 2004;109(8):990-6.
Fig 10: ECG patterns of different types of Brugada 10. Pastore JM, Laurita KR, Rosenbaum DS. Importance of spatiotemporal
syndromes. heterogeneity of cellular restitution in mechanism of arrhythmogenic dis-
cordant alternans. Heart Rhythm. 2006;3(6):711-9.
D. Newer markers for risk stratification: 11. Dinov B, Bode K, Koenig S, Oebel S, Sommer P, Bollmann A, et al. Sig-
nal-Averaged Electrocardiography as a Noninvasive Tool for Evaluating the
Non invasive ecg markers such as T wave alternans Outcomes After Radiofrequency Catheter Ablation of Ventricular Tachy-
(9, 10), heart rate variability(9) and late potentials (de- cardia in Patients With Ischemic Heart Disease: Reassessment of an Old
tected by SAECG) (11) have been found to have higher Tool. Circ Arrhythm Electrophysiol. 2016;9(9).
incidence of sudden cardiac arrests in some studies.
However, they have not found of much utility in clin-
ical practise(9).
Highlights:
Syncope is a benign disorder in majority of patients.
It is important to rule out cardiac/arrhthymic etiology
as these patients have higher mortality in the long
term.
A detailed history and a meticulous physical exam-
ination constitute the first step towards evaluation of
patients with syncope.
Precise interpretation of the ECG is important to iden-
tify cardiac etiology of syncope.
References:
1. Task Force for the D, Management of S, European Society of C, European
Heart Rhythm A, Heart Failure A, Heart Rhythm S, et al. Guidelines for
the diagnosis and management of syncope (version 2009). Eur Heart J.
2009;30(21):2631-71.
GCDC 2017

